Tayyaba Rafiq et al. 2024. THE PROGNOSTIC SIGNIFICANCE OF PD-L1 EXPRESSION IN IMMUNE CHECKPOINT THERAPY FOR DIVERSITY IN HEAD AND NECK TUMORS ASSESSMENTS, INSIGHTS TO MOLECULAR ONCOLOGY THERAPEUTICS. Journal of Population Therapeutics and Clinical Pharmacology. 31, 8 (Aug. 2024), 3453–3459. DOI:https://doi.org/10.53555/gh4hse49.